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Background: The incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) is growing
at an alarming rate. It is widely believed that the rising ESRD population is just the tip of the CKD iceberg.
Data on early-stage CKD and the prevalence of CKD in India are very limited. Therefore, data from a renal
camp organized in connection with World Kidney Day were looked at for renal function.
Methods: This was a cross-sectional study. A renal camp was advertised using a set of eight questions; any
person who answered yes to one or more questions were advised to attend the camp. Body weight, height, blood
pressure, blood sugar and serum creatinine were measured. Urine examination for sugar, albumin and blood was
carried out. Renal function was assessed by calculating the glomerular filtration rate (GFR) using the Cockcroft-
Gault (C-G) and Modified Diet in Renal Disease (MDRD) formulas. Kidney function was classified according to
estimated GFR (eGFR) and Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines.
Results: A total of 123 people (82.1% male) were studied; 9% were less than 20 years old and 26% were aged
60 years or older. The distribution of eGFR was symmetrical, with the majority of people in the 70–79 mL/min
category; 69.9% of the study population had eGFR < 100 mL/min. There was a gradual increase in eGFR from
the < 20-year-old group to the 30–39-year-old group (which had the highest eGFR of about 110 mL/min), and
then a gradual decline with increasing age. An inverse relation between eGFR and age was observed: eGFR
declined by 1 mL/min/year (95% confidence interval, 0.7–1.3). C-G eGFR indicated that about 69% of the
study population was normal and 31% had CKD stage I to V. MDRD eGFR indicated that 7.3% had CKD stage
III to V. Only in CKD stages IV and V could elevated levels of serum creatinine be seen.
Conclusion: The results indicate low GFR levels and, consequently, a high burden of CKD in the Indian
population. It is not clear whether such observations are the result of the transportability problems associated
with the GFR prediction equations or with the suitability of K/DOQI guidelines for the classification of CKD
in the Indian population or both. Well-planned, larger, community- and hospital-based studies are warranted to
clarify these issues. [Hong Kong J Nephrol 2008;10(1):27–33]
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INTRODUCTION
The incidence of chronic kidney disease (CKD) and
end-stage renal disease (ESRD) is growing at an
alarming rate. It is widely believed that the rising ESRD
population is just the tip of the CKD iceberg. For each
patient with ESRD, there are over 100 patients with
various stages of CKD in the US [1,2]. It is estimated
that about 100,000 people develop ESRD in India each
year [3]. However, this figure may be an underestimate
as it is projected from only a few tertiary care centers
in urban areas. Generally, most CKD patients who
report to these tertiary care centers are already in the
end stages. Data on early-stage CKD and the prevalence
of CKD are very limited [4–7]. In view of this,
information on the various aspects of CKD from
different geographic regions of a vast country like India
will aid in better understanding of the issues related to
CKD. A renal camp was organized to coincide with
World Kidney Day in the city of Hyderabad; the renal
function and CKD of subjects who attended the renal
camp were analyzed.
METHODS
On March 9, 2006, we organized a free renal camp in
Hyderabad, the capital city of the state of Andhra
Pradesh in India. The camp was advertised in a few
local vernacular dailies 2 weeks before the scheduled
date of commencement; the advertisement advised
people to attend the camp if they answered yes to one
or more of the following questions:
1. Do you have diabetes?
2. Do you have hypertension?
3. Do you have burning micturition?
4. Do you have red colored urine?
5. Do have difficulty in passing urine?
6. Have you ever passed stones in your urine?
7. Have you ever been told about kidney problems?
8. Is there a history of diabetes/hypertension/kidney
disease in your family?
The same advertisement was also broadcast on two
local television channels in Hyderabad 2 days before
the camp.
However, everyone who turned up for the camp was
included in the study, regardless of whether or not they
had answered the eight questions. This was because
the camp was organized as a free service to the public,
with the idea that it might serve to raise awareness and
to educate the public in general.
Body weight, height and blood pressure were
measured for all subjects attending the camp. Blood
was collected for sugar and serum creatinine estimation.
Urine was examined for sugar, albumin and blood.
Blood sugar was measured using a glucometer; serum
creatinine measurement was done by a Hitachi
automatic analyzer. The dipstick method was used for
urine examination.
Renal function was assessed by calculating the
glomerular filtration rate (GFR) with the Cockcroft-
Gault (C-G) formula [8] and the simplified Modified
Diet in Renal Disease (MDRD) formula [9]. Using these
estimated GFRs (eGFRs) and the Kidney Disease
Outcomes Quality Initiative (K/DOQI) guidelines,
kidney functioning was classified for each subject.
Persons with a low eGFR or who were suspected to
have CKD were advised to undergo detailed
investigations in the nephrology clinic at Nizam’s
Institute.
The distribution of the C-G formula-based GFR was
assessed using the coefficient of skewness and kurtosis.
Mean, standard deviation (SD), median, range, 5th and
95th percentiles were calculated. The 95% confidence
intervals (CI) were calculated. The relation between
age and eGFR was assessed using simple linear
regression. All analyses were performed using Stata
version 9.1 (Stata Corp., College Park, Texas, USA).
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RESULTS
Description of the study population
A total of 131 people attended the camp. Blood and/or
urine sample results were not available for eight subjects
so they were excluded from analysis. Data from the
remaining 123 subjects were analysed. The majority
of subjects (82.1%) were men. The mean age (± SD)
of the population was 50.4 (± 15.1) years; 9% were
younger than 20 years and 26% were * 60 years old.
Mean systolic and diastolic blood pressures were 128.9
± 17.8 mmHg and 83.6 ± 11.4 mmHg, respectively.
About one third of people who attended the camp had
diabetes (35%) or hypertension (34%). Both conditions
were present in 23 (23/123 = 18.7%). One third of the
subjects (33.33%, 41/123) did not report a history of
any of the eight problems listed in the advertisement.
One of the eight problems was present in 35.77%
(44/123) of the subjects, two problems were present in
27.64%, and three were present in 3.25%.
Distribution of eGFR
The distribution of eGFR is shown in Figure 1. It was
symmetrical, with the majority of people in the 70–79
mL/min category. The mean and median GFR were
close to each other (85.0 and 82.0 mL/min,
respectively). More than two thirds (69.9%) of the study
population had eGFR < 100 mL/min. Less than 10%
had eGFR > 120 mL/min.
The distribution of eGFR was slightly positively
skewed (coefficient of skewness, 0.18) and the
distribution curve was slightly leptokurtic (coefficient,
3.4). Thus, the distribution of eGFR was close to that
of a normal distribution, which has a skewness of zero
and kurtosis of 3.0.
Age-wise distribution of eGFR
Table 1 depicts the age-wise distribution (frequency,
mean, 95% CI of mean, median, range, 5th and 95th
percentiles) of eGFR. On average, the highest values
of eGFR were observed in the age group of 30–39 years,
where it was about 110 mL/min. The 5th and 95th
percentiles in this age group were 71 and 157 mL/min,
respectively. There was a gradual increase in eGFR
from the < 20-year-old group to the 30–39-year-old
group, and then a gradual decline with increasing age.
Association of eGFR with age
Figure 2 shows the relation between age and eGFR;
there was an inverse relation between the two. Simple
linear regression analysis indicated that eGFR declined
by 1 mL/min (95% CI, 0.7–1.3) with each 1 year
increase in age.
CKD stages in the study population
Assuming that traces of albumin in the urine is transient
albuminuria and 1+ to 4+ is persistent albuminuria, the
various stages of CKD, as per the K/DOQI guidelines,
in the study population is shown in Table 2. C-G formula-
based eGFR indicated that about 69% of the study
population was normal (GFR * 60 mL/min and no signs
of renal damage as evidenced by albuminuria). About
31% had CKD stage I to V. Even after considering
albuminuria of 1+ as transient, this proportion remained
high (23.6%). Using MDRD-based eGFR, only 7.3%
had CKD stage III to V. The corresponding frequency
for C-G formula-based eGFR was 16.2%, indicating a
significant disparity between the two formulas.
GFR and creatinine in various stages of CKD
The correspondence between eGFR and serum
Figure 1. Distribution of estimated
glomerular filtration rate (GFR)
calculated by the Cockcroft-Gault
equation.
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Table 1. Age-wise distribution of estimated glomerular filtration rate (GFR) calculated by the Cockcroft-Gault equation
GFR (mL/min)
Age (yr) Freq Mean (95% CI) Median Range 5th percentile 95th percentile
< 20 3 102.7 (72.81–132.53) 90 85–133 85 133
20–29 8 101.2 (88.47–114.03) 96.5 77–126 77 126
30–39 22 107.3 (94.49–120.06) 110 13–164 71 157
40–49 24 93.4 (83.34–103.41) 95 15–154 70 115
50–59 30 79.6 (71.85–87.35) 79.5 21–149 55 125
* 60 32 62.2 (56.19–68.25) 60.5 30–114 38 101
Unknown 4 88.5 (77.00–100.00) 86 78–104 78 104
All ages 123 85.0 (80.06–89.89) 82 13–164 44 127
creatinine values among the various stages of CKD
(as per K/DOQI definition) is presented in Table 3. It
is interesting to note that the creatinine levels were
not elevated even in stage III CKD, although GFR
indicated the presence of the disease. Only in CKD
stages IV and V could elevated levels of serum
creatinine be seen. This indicates that if we depend
on serum creatinine alone, there is a high probability
of missing the diagnosis of CKD when it is in the early
stages.
Table 2. Distribution of chronic kidney disease (CKD) according to Kidney Disease Outcomes Quality Initiative definitions
CKD status
C-G formula* C-G formula† MDRD formula
n (%) n (%) n (%)
Normal 85 (69.11) 94 (76.42) 114 (92.68)
Stage I 8 (6.50) 3 (2.43) –
Stage II 10 (8.13) 6 (4.88) –
Stage III 17 (13.82) 17 (13.82) 5 (4.07)
Stage IV 2 (1.63) 2 (1.63) 2 (1.63)
Stage V 1 (0.81) 1 (0.81) 2 (1.63)
Total 123 (100) 123 (100) 123 (100)
*Assuming traces of albuminuria as transient; †assuming traces and 1+ of albuminuria as transient. C-G = Cockcroft-Gault; MDRD =
Modified Diet in Renal Disease.
Figure 2. Association of
estimated glomerular
filtration rate (GFR) with
age. Regression equation:
GFR = 136.62 – (age × 1.03).
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DISCUSSION
We examined the renal function of a sample of an urban
population who attended a renal camp. The distribution
of GFR in the study population was estimated by the
C-G formula as a quick and feasible method suitable
for the study setting.
We observed an average GFR level of 85 mL/min
in this population, which is on the lower side of the
generally accepted values for normal GFR estimates.
About 40% of our study population had GFR > 90 mL/
min, which might be due to the camp approach as more
people with renal problems would attend the camp,
leading to the observation of poor or low GFR profiles.
We do not know the average GFR level in the Indian
community and hence it is difficult to make any
conclusions. On the other hand, there could be reasons
for overestimation of GFR in our study population.
First, the samples were obtained during the day, when
GFR is expected to be at its highest [10]. Second, it
has been reported that the C-G formula overestimates
true GFR [11]. Despite these, an observation of a low
profile of eGFR indicates that the general level of GFR
in the community itself might be low. However, this
needs to be confirmed or contradicted by way of
community-based studies. In any case, there is a need
to define the GFR profiles in normal subjects as well
as in patients with renal insufficiency in the Indian
population, and our results are useful from that
perspective.
The frequency distribution of GFR was close to that
of a normal distribution, with a mean of 85 and SD of
27.8 mL/min. It is easy to know the proportion of the
population with various ranges of GFR if we know the
mean and SD of the GFR of that population, and given
that the GFR follows a normal distribution. Further, an
observation of the normal nature of the GFR might be
helpful for the purpose of statistical analysis involving
GFR. However, we could not find any other report on
the nature of the distribution of GFR or eGFR in the
community.
The age-wise distribution of GFR indicated that the
peak was in the age group of 30–39 years. Gender-
specific analysis confirmed similar observations in both
males and females. Though not significant, GFR was,
on average, 4 mL/min lower in females than in males.
As per the K/DOQI definition of CKD, we observed
a very high proportion (30.9%) of CKD in the study
population. Even if albuminuria of 1+ grade was taken
as transient, 23.6% of the study population would be
categorized as having CKD stage I to V. The same
arguments for the observation of low GFR profiles hold
for this observation too. In addition, it also raises the
question of whether or not the cut-offs recommended
by the K/DOQI guidelines for the various stages of
CKD are applicable for all populations worldwide.
Ideally, any international recommendations should be
based on international data. However, a number of
investigators believe that the use of prediction equations
in population-based studies suggest a surprisingly high
prevalence of CKD [12–14]. This leads to doubt in the
utility of these equations in epidemiologic research. The
transportability problem [15], i.e. validity of these
formulas to other populations with different
characteristics, needs to be addressed before
commenting on this. Another contributing factor may
be related to the issue of measurement methodology
and calibration of serum creatinine [16]. On the whole,
the burden of CKD in this small population was much
higher compared to the available prevalence/incidence
data on the Indian population [5–7]. The difference may
be partly due to the fact that the earlier studies did not
depend on GFR/eGFR but on serum creatinine/clinical
judgment.
The apparently lower level of eGFR results in
problems of staging due to fixed cut-offs in the K/DOQI
classification of CKD stages. Actually, it is not known
if the classification can be applied to the Indian
population. Whether the lower level of GFR in the
population indicates a greater susceptibility to
developing ESRD or proportionately lower cut-off
values at each stage are required is not known.




status Mean (95% CI) Median Range Mean (95% CI) Median Range
Normal 85 92.1 (87.71–96.55) 90 60–154 0.92 (0.88–0.96) 0.90 0.3–1.3
Stage I 8 121.1 (99.91–142.34) 108 91–164 0.95 (0.89–1.01) 0.95 0.8–1.1
Stage II 10 74.7 (72.27– 77.13) 74.0 67–81 1.09 (0.96–1.22) 1.05 0.9–1.5
Stage III 17 50.4 (46.48–54.23) 54.0 30–59 1.22 (1.03–1.40) 1.20 0.8–2.6
Stage IV 2 18.0 (12.12–23.88) 18.0 15–21 4.45 (3.18–5.72) 4.45 3.8–5.1
Stage V 1 13.0 (–) 13.0 – 6.30 (–) 6.30 –
Total 123 85.0 (80.06–89.89) 82.0 13–164 1.08 (0.96–1.20) 1.00 0.3–6.3
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The finding that there is a consistently lower prevalence
of decreased GFR among African Americans across all
age groups and yet a disproportionately higher
frequency with ESRD (compared to White Americans)
indicates that there is a differential risk [12]. In other
words, there exists heterogeneity in the risk of
progressive renal disease for the same cross-sectional
category of GFR. The crucial question is whether the
lower GFR levels in the Indian population indicate a
greater risk for developing CKD early or if a different
set of guidelines from the existing K/DOQI guidelines
are required.
While  s taging CKD as  per  the  K/DOQI
classification, we considered only albuminuria as an
evidence of kidney damage; cases of hematuria were
ignored. An effect of this might be that the incidence
of CKD was underestimated, however minimal the
effect might be.
The staging of CKD based on the C-G and MDRD
formulas show divergence. The prevalence of stage III
CKD was 13.82% according to the C-G formula, but
4.07% according to the MDRD formula. However,
stage V prevalence as calculated by the C-G formula
was only about half of that calculated by the MDRD
formula (0.81% vs. 1.63%). The divergence between
the two formulas is well known because the biases of
the two formulas may be quite different in selected
populations, defined by age, sex, body mass index and
also level of GFR [17]. Regarding the MDRD formula,
it may be stated at present that in its available form, it
only picks up stage III or above.
We observed a linear negative correlation between
age and GFR. The proportion of variation in GFR
explained by age (r2) was 32.0% (p < 0.001). GFR
declined by 1 mL/min for each 1 year of increase in
age. This is in agreement with other reports based on
cross-sectional data [12], but slightly more than the
decline based on longitudinal data [18,19].
The correspondence between eGFR and serum
creatinine values among the various stages of CKD led
to the interesting observation that serum creatinine
levels were not elevated even in CKD stage III, though
the GFR indicated derangement or presence of disease.
Only in CKD stages IV and V could elevated levels of
serum creatinine be seen. Thus, if we depend on serum
creatinine alone, there is a possibility of missing the
diagnosis of the disease when it is in its earlier stages.
Similar views have also been reported previously [20,
21].
Our results are based on only 123 subjects, who were
likely to be different from the general population of
the community by virtue of them attending the renal
camp in response to the advertisement listing the eight
problems. The results therefore need to be interpreted
with this in mind. Only one-time measurements of
urinary albumin and serum creatinine, and a lack of
calibration of the measurement of serum creatinine are
some of the limitations of the study.
To conclude, the results of this study indicate that
GFR levels in the Indian population are on the lower
side of the generally accepted normal values. The
burden of CKD, even if we consider the high-risk nature
of the camp population, was much higher than expected.
It is not clear whether this observation was the result
of the transportability problems associated with the
GFR prediction equations or with the suitability of the
K/DOQI guidelines for classifying CKD in an Indian
population or with both. Well planned and larger
community- and hospital-based studies are warranted
to clarify these issues. Pending such studies, revisiting
the data from earlier reports that estimated the
prevalence of CKD, based on serum creatinine, in India
would help to assess the prevalence of various stages
of CKD and the GFR profiles in the community. The
lack of correspondence between serum creatinine and
eGFR should be accepted and eGFR should be adopted
for the early diagnosis of CKD.
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